Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|December 30, 2020
Implications of viral transmitted/founder (T/F) dynamics on vaccine developmentAlexander I Mosa
Frontiers in Immunology|October 5, 2020
Antigenic VariabilityAlexander I Mosa
Canadian Journal of Kidney Health and Disease|December 22, 2022
Impacting Management of Chronic Kidney Disease Through Primary Care Practice Audits: A Quality Improvement StudyAlexander I Mosa, Don Watts, Navdeep Tangri
Viruses|August 26, 2022
HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus InfectionMuhammad Atif Zahoor, Adrian Kuipery, Alexander I Mosa, et al.
Vaccine|September 9, 2020
A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in miceAlexander I Mosa, Richard A Urbanowicz, Mounir G AbouHaidar, et al.
Virology Journal|September 19, 2020
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCVAlexander I Mosa, Mounir G AbouHaidar, Richard A Urbanowicz, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
Development of a CRE/CREB-driven HBx responsive HBV cell culture reporter system for antiviral drug evaluationMuhammad Atif Zahoor, Nahla FadlElMawla, Adrian Kuipery, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virusAlexander I Mosa, David S Campo, Yury Khudyakov, et al.
Hepatology (Baltimore, Md.)|April 17, 2024
Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN TrialsMuhammad Atif Zahoor, Joshua B Feld, Hsing-Hua Sylvia Lin, et al.
Pageof 1